IRF-5 activators belong to a distinctive category of chemical compounds that have drawn significant attention in the realm of molecular biology and immunology. These compounds are renowned for their ability to modulate the function of Interferon Regulatory Factor 5 (IRF-5), a pivotal transcription factor with a crucial role in orchestrating the immune response. IRF-5 is predominantly expressed within immune cells like macrophages and dendritic cells, acting as a central player in the initiation and regulation of inflammatory responses in the body. IRF-5 activators are designed with the purpose of enhancing IRF-5's transcriptional activity, thereby leading to the upregulation of genes closely associated with immune response regulation. This activation of IRF-5 can have wide-ranging effects on the immune system, influencing various aspects of immune surveillance and inflammatory processes.
In terms of chemical composition, IRF-5 activators manifest in diverse forms, encompassing small organic molecules and synthetic compounds intricately tailored to interact with IRF-5 or its associated signaling pathways. These compounds function by binding to IRF-5 or its regulatory partners, thereby modulating their activity and subsequently influencing the downstream immune response. While the precise mechanisms of action can diverge among different IRF-5 activators, they all share a common goal of intensifying immune responses. Elucidating the molecular interactions and mechanisms behind IRF-5 activators has offered valuable insights into the intricate orchestration of the immune system. This research holds promise for a wide array of fields, including immunology, infectious diseases, and autoimmune disorders, as it continues to unravel the complex web of molecular pathways governing immune responses.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $66.00 $278.00 | 6 | |
Imiquimod acts on the immune system through toll-like receptor 7, which can lead to the induction of IRF-5 as part of the antiviral response. | ||||||
Polyinosinic-polycytidylic acid potassium salt | 31852-29-6 | sc-202767 | 5 mg | $194.00 | ||
Polyinosinic-polycytidylic acid potassium salt mimics viral RNA and is recognized by toll-like receptor 3, which may induce IRF-5 expression as part of the antiviral defense mechanism. | ||||||
Gardiquimod | 1020412-43-4 | sc-221663 sc-221663A sc-221663B sc-221663C sc-221663D sc-221663E sc-221663F | 25 mg 50 mg 100 mg 250 mg 5 g 10 g 25 g | $154.00 $276.00 $506.00 $1154.00 $19743.00 $32136.00 $69366.00 | 1 | |
Gardiquimod targets TLR7 and may lead to the activation of signaling pathways that increase the expression of IRF-5 in immune cells. | ||||||
R-848 | 144875-48-9 | sc-203231 sc-203231A sc-203231B sc-203231C | 5 mg 25 mg 100 mg 500 mg | $100.00 $300.00 $500.00 $1528.00 | 12 | |
Similar to other TLR agonists, R848 can stimulate the innate immune system and potentially enhance the expression of IRF-5. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
Chloroquine can modulate immune system activity, which may affect the expression of IRF-5 in a complex manner, possibly through endosomal toll-like receptor signaling pathways. | ||||||
Bafilomycin A1 | 88899-55-2 | sc-201550 sc-201550A sc-201550B sc-201550C | 100 µg 1 mg 5 mg 10 mg | $96.00 $250.00 $750.00 $1428.00 | 280 | |
Bafilomycin A1 inhibits vacuolar H+ ATPase and can interfere with endosomal acidification, potentially impacting toll-like receptor signaling and thus IRF-5 expression. | ||||||